ArticleCells2021

Alkylaminophenol and GPR17 Agonist for Glioblastoma Therapy: A Combinational Approach for Enhanced Cell Death Activity.

Phuong Doan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.